455 related articles for article (PubMed ID: 19940755)
21. Update on nephrogenic systemic fibrosis.
Thomsen HS; Marckmann P; Logager VB
Magn Reson Imaging Clin N Am; 2008 Nov; 16(4):551-60, vii. PubMed ID: 18926421
[TBL] [Abstract][Full Text] [Related]
22. Nephrogenic systemic fibrosis: is gadolinium to be blamed?
Jikki PN
J Assoc Physicians India; 2008 Nov; 56():915-6. PubMed ID: 19263697
[No Abstract] [Full Text] [Related]
23. Pathomechanisms of nephrogenic systemic fibrosis: new insights.
Gupta A; Shamseddin MK; Khaira A
Clin Exp Dermatol; 2011 Oct; 36(7):763-8. PubMed ID: 21790732
[TBL] [Abstract][Full Text] [Related]
24. Nephrogenic systemic fibrosis: clinical picture and treatment.
Marckmann P; Skov L
Radiol Clin North Am; 2009 Sep; 47(5):833-40, vi. PubMed ID: 19744598
[TBL] [Abstract][Full Text] [Related]
25. Nephrogenic systemic fibrosis in advanced chronic kidney disease: a single hospital's experience in Taiwan.
Chen W; Huang SL; Huang CS; Tsai MC; Lai HM; Lui CC; Eng HL; Chang HW; Lee CH; Chuang FR
Eur J Dermatol; 2009; 19(1):44-9. PubMed ID: 19059824
[TBL] [Abstract][Full Text] [Related]
26. Gadolinium-based contrast agents and NSF: evidence from animal experience.
Sieber MA; Steger-Hartmann T; Lengsfeld P; Pietsch H
J Magn Reson Imaging; 2009 Dec; 30(6):1268-76. PubMed ID: 19938039
[TBL] [Abstract][Full Text] [Related]
27. Involvement of gadolinium chelates in the mechanism of nephrogenic systemic fibrosis: an update.
Idée JM; Port M; Dencausse A; Lancelot E; Corot C
Radiol Clin North Am; 2009 Sep; 47(5):855-69, vii. PubMed ID: 19744600
[TBL] [Abstract][Full Text] [Related]
28. Erythema nodosum masking nephrogenic systemic fibrosis as initial skin manifestation.
Fuah KW; Lim CTS
BMC Nephrol; 2017 Jul; 18(1):249. PubMed ID: 28738858
[TBL] [Abstract][Full Text] [Related]
29. Nephrogenic systemic fibrosis.
Weinreb JC; Kuo PH
Magn Reson Imaging Clin N Am; 2009 Feb; 17(1):159-67. PubMed ID: 19364606
[TBL] [Abstract][Full Text] [Related]
30. Gadolinium-containing magnetic resonance imaging contrast and nephrogenic systemic fibrosis: a case-control study.
Kallen AJ; Jhung MA; Cheng S; Hess T; Turabelidze G; Abramova L; Arduino M; Guarner J; Pollack B; Saab G; Patel PR
Am J Kidney Dis; 2008 Jun; 51(6):966-75. PubMed ID: 18501784
[TBL] [Abstract][Full Text] [Related]
31. Nephrogenic systemic fibrosis: histology and gadolinium detection.
Thakral C; Abraham JL
Radiol Clin North Am; 2009 Sep; 47(5):841-53, vi-vii. PubMed ID: 19744599
[TBL] [Abstract][Full Text] [Related]
32. Nephrogenic systemic fibrosis with a spectrum of clinical and histopathological presentation: a disorder of aberrant dermal remodeling.
Deng A; Martin DB; Spillane A; Chwalek J; St Surin-Lord S; Brooks S; Petrali J; Sina B; Gaspari A; Kao G
J Cutan Pathol; 2010 Feb; 37(2):204-10. PubMed ID: 19341434
[TBL] [Abstract][Full Text] [Related]
33. Clinical and histological findings in nephrogenic systemic fibrosis.
Cowper SE; Rabach M; Girardi M
Eur J Radiol; 2008 May; 66(2):191-9. PubMed ID: 18325705
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of NSF following intravenous gadolinium-contrast media administration in dialysis patients with endstage renal disease.
Heinz-Peer G; Neruda A; Watschinger B; Vychytil A; Geusau A; Haumer M; Weber M
Eur J Radiol; 2010 Oct; 76(1):129-34. PubMed ID: 19619969
[TBL] [Abstract][Full Text] [Related]
35. Gadolinium-induced nephrogenic systemic fibrosis is associated with insoluble Gd deposits in tissues: in vivo transmetallation confirmed by microanalysis.
Thakral C; Abraham JL
J Cutan Pathol; 2009 Dec; 36(12):1244-54. PubMed ID: 19602073
[TBL] [Abstract][Full Text] [Related]
36. Nephrogenic systemic fibrosis: a review of the new conundrum.
Goenka AH; Das CJ; Sharma R
Natl Med J India; 2009; 22(6):302-6. PubMed ID: 20384019
[TBL] [Abstract][Full Text] [Related]
37. [Nephrogenic systemic fibrosis].
Artunc F; Schanz S; Metze D; Heyne N
Dtsch Med Wochenschr; 2008; 133 Suppl():F1. PubMed ID: 18802876
[TBL] [Abstract][Full Text] [Related]
38. Gadolinium-associated nephrogenic systemic fibrosis.
Schlaudecker JD; Bernheisel CR
Am Fam Physician; 2009 Oct; 80(7):711-4. PubMed ID: 19817341
[TBL] [Abstract][Full Text] [Related]
39. Time-dependent decrement of dermal gadolinium deposits and significant improvement of skin symptoms in a patient with nephrogenic systemic fibrosis after temporary renal failure.
Schäd SG; Heitland P; Kühn-Velten WN; Gross GE; Jonas L
J Cutan Pathol; 2013 Nov; 40(11):935-44. PubMed ID: 24102613
[TBL] [Abstract][Full Text] [Related]
40. Nephrogenic systemic fibrosis and gadolinium-based contrast agents.
Abu-Alfa AK
Adv Chronic Kidney Dis; 2011 May; 18(3):188-98. PubMed ID: 21531325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
